Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Pharma & Healthcare

Published Date: 2025-03-19

Pages: 79 Pages

Report ld: 4682849

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Industry Insights:

Urokinase Research：CAGR of 4.7% during the forecast period

Urokinase Market Size(US$)

CAGR 2025-2031

5.2%

Market Size,2031

USD 70.6

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 52.1 million

Market Forecast in 2031(Value)

US$ 70.6 million

CAGR

5.2%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Urokinase market size was US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.

Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.

Global key players of urokinase include Syner-Med, LIVZON, Wanhua Biochem, etc. The top three players hold a share about 50%. China is the largest market of Urokinase, holding a share about 56%, followed by Europe and North America.

The global Urokinase market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.

MARKET SEGMENTATION

By Company

Syner-Med
Wanhua Biochem
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical
Techpool
Microbic Biosystems
LIVZON

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Urokinase Powder
Urokinase Solution

Segment by Application

Hospital
Clinic
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

Chapter 2: Quantitative analysis of Urokinase market size and growth potential at global, regional, and country levels.

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Urokinase Solution in China).

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Clinic in India).

Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 9: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:

- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).

- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Urokinase Powder dominance in Europe vs. Urokinase Solution demand in MEA).

- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Urokinase Product Scope

1.2 Urokinase by Type

1.2.1 Global Urokinase Sales by Type (2020 & 2024 & 2031)

1.2.2 Urokinase Powder

1.2.3 Urokinase Solution

1.3 Urokinase by Application

1.3.1 Global Urokinase Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Urokinase Market Estimates and Forecasts (2020-2031)

1.4.1 Global Urokinase Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Urokinase Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Urokinase Price Trends (2020-2031)

1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

2.1 Global Urokinase Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Urokinase Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Urokinase Sales Market Share by Region (2020-2025)

2.2.2 Global Urokinase Revenue Market Share by Region (2020-2025)

2.3 Global Urokinase Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Urokinase Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Urokinase Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 North America Urokinase Market Size and Prospective (2020-2031)

2.4.2 Europe Urokinase Market Size and Prospective (2020-2031)

2.4.3 China Urokinase Market Size and Prospective (2020-2031)

3 Global Market Size by Type

3.1 Global Urokinase Historic Market Review by Type (2020-2025)

3.1.1 Global Urokinase Sales by Type (2020-2025)

3.1.2 Global Urokinase Revenue by Type (2020-2025)

3.1.3 Global Urokinase Price by Type (2020-2025)

3.2 Global Urokinase Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global Urokinase Sales Forecast by Type (2026-2031)

3.2.2 Global Urokinase Revenue Forecast by Type (2026-2031)

3.2.3 Global Urokinase Price Forecast by Type (2026-2031)

3.3 Different Types Urokinase Representative Players

4 Global Market Size by Application

4.1 Global Urokinase Historic Market Review by Application (2020-2025)

4.1.1 Global Urokinase Sales by Application (2020-2025)

4.1.2 Global Urokinase Revenue by Application (2020-2025)

4.1.3 Global Urokinase Price by Application (2020-2025)

4.2 Global Urokinase Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Urokinase Sales Forecast by Application (2026-2031)

4.2.2 Global Urokinase Revenue Forecast by Application (2026-2031)

4.2.3 Global Urokinase Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Urokinase Application

5 Competition Landscape by Players

5.1 Global Urokinase Sales by Players (2020-2025)

5.2 Global Top Urokinase Players by Revenue (2020-2025)

5.3 Global Urokinase Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urokinase as of 2024)

5.4 Global Urokinase Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Urokinase, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Urokinase, Product Type & Application

5.7 Global Key Manufacturers of Urokinase, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Urokinase Sales by Company

6.1.1.1 North America Urokinase Sales by Company (2020-2025)

6.1.1.2 North America Urokinase Revenue by Company (2020-2025)

6.1.2 North America Urokinase Sales Breakdown by Type (2020-2025)

6.1.3 North America Urokinase Sales Breakdown by Application (2020-2025)

6.1.4 North America Urokinase Major Customer

6.1.5 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Urokinase Sales by Company

6.2.1.1 Europe Urokinase Sales by Company (2020-2025)

6.2.1.2 Europe Urokinase Revenue by Company (2020-2025)

6.2.2 Europe Urokinase Sales Breakdown by Type (2020-2025)

6.2.3 Europe Urokinase Sales Breakdown by Application (2020-2025)

6.2.4 Europe Urokinase Major Customer

6.2.5 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Urokinase Sales by Company

6.3.1.1 China Urokinase Sales by Company (2020-2025)

6.3.1.2 China Urokinase Revenue by Company (2020-2025)

6.3.2 China Urokinase Sales Breakdown by Type (2020-2025)

6.3.3 China Urokinase Sales Breakdown by Application (2020-2025)

6.3.4 China Urokinase Major Customer

6.3.5 China Market Trend and Opportunities

7 Company Profiles and Key Figures

7.1 Syner-Med

7.1.1 Syner-Med Company Information

7.1.2 Syner-Med Business Overview

7.1.3 Syner-Med Urokinase Sales, Revenue and Gross Margin (2020-2025)

7.1.4 Syner-Med Urokinase Products Offered

7.1.5 Syner-Med Recent Development

7.2 Wanhua Biochem

7.2.1 Wanhua Biochem Company Information

7.2.2 Wanhua Biochem Business Overview

7.2.3 Wanhua Biochem Urokinase Sales, Revenue and Gross Margin (2020-2025)

7.2.4 Wanhua Biochem Urokinase Products Offered

7.2.5 Wanhua Biochem Recent Development

7.3 Jiangxi Haoran Bio-Pharma

7.3.1 Jiangxi Haoran Bio-Pharma Company Information

7.3.2 Jiangxi Haoran Bio-Pharma Business Overview

7.3.3 Jiangxi Haoran Bio-Pharma Urokinase Sales, Revenue and Gross Margin (2020-2025)

7.3.4 Jiangxi Haoran Bio-Pharma Urokinase Products Offered

7.3.5 Jiangxi Haoran Bio-Pharma Recent Development

7.4 Jiangsu Aidea Pharmaceutical

7.4.1 Jiangsu Aidea Pharmaceutical Company Information

7.4.2 Jiangsu Aidea Pharmaceutical Business Overview

7.4.3 Jiangsu Aidea Pharmaceutical Urokinase Sales, Revenue and Gross Margin (2020-2025)

7.4.4 Jiangsu Aidea Pharmaceutical Urokinase Products Offered

7.4.5 Jiangsu Aidea Pharmaceutical Recent Development

7.5 Techpool

7.5.1 Techpool Company Information

7.5.2 Techpool Business Overview

7.5.3 Techpool Urokinase Sales, Revenue and Gross Margin (2020-2025)

7.5.4 Techpool Urokinase Products Offered

7.5.5 Techpool Recent Development

7.6 Microbic Biosystems

7.6.1 Microbic Biosystems Company Information

7.6.2 Microbic Biosystems Business Overview

7.6.3 Microbic Biosystems Urokinase Sales, Revenue and Gross Margin (2020-2025)

7.6.4 Microbic Biosystems Urokinase Products Offered

7.6.5 Microbic Biosystems Recent Development

7.7 LIVZON

7.7.1 LIVZON Company Information

7.7.2 LIVZON Business Overview

7.7.3 LIVZON Urokinase Sales, Revenue and Gross Margin (2020-2025)

7.7.4 LIVZON Urokinase Products Offered

7.7.5 LIVZON Recent Development

8 Urokinase Manufacturing Cost Analysis

8.1 Urokinase Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Urokinase

8.4 Urokinase Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Urokinase Distributors List

9.3 Urokinase Customers

10 Urokinase Market Dynamics

10.1 Urokinase Industry Trends

10.2 Urokinase Market Drivers

10.3 Urokinase Market Challenges

10.4 Urokinase Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Urokinase Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Urokinase Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Urokinase Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Urokinase Sales (BIU) by Region (2020-2025)

Table 5. Global Urokinase Sales Market Share by Region (2020-2025)

Table 6. Global Urokinase Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Urokinase Revenue Share by Region (2020-2025)

Table 8. Global Urokinase Sales (BIU) Forecast by Region (2026-2031)

Table 9. Global Urokinase Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Urokinase Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Urokinase Revenue Share Forecast by Region (2026-2031)

Table 12. Global Urokinase Sales by Type (BIU) & (2020-2025)

Table 13. Global Urokinase Sales Share by Type (2020-2025)

Table 14. Global Urokinase Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Urokinase Price by Type (US$/MIU) & (2020-2025)

Table 16. Global Urokinase Sales by Type (BIU) & (2026-2031)

Table 17. Global Urokinase Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Urokinase Price by Type (US$/MIU) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Urokinase Sales by Application (BIU) & (2020-2025)

Table 21. Global Urokinase Sales Share by Application (2020-2025)

Table 22. Global Urokinase Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Urokinase Price by Application (US$/MIU) & (2020-2025)

Table 24. Global Urokinase Sales by Application (BIU) & (2026-2031)

Table 25. Global Urokinase Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Urokinase Price by Application (US$/MIU) & (2026-2031)

Table 27. New Sources of Growth in Urokinase Application

Table 28. Global Urokinase Sales by Company (BIU) & (2020-2025)

Table 29. Global Urokinase Sales Share by Company (2020-2025)

Table 30. Global Urokinase Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Urokinase Revenue Share by Company (2020-2025)

Table 32. Global Urokinase by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urokinase as of 2024)

Table 33. Global Market Urokinase Average Price by Company (US$/MIU) & (2020-2025)

Table 34. Global Key Manufacturers of Urokinase, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Urokinase, Product Type & Application

Table 36. Global Key Manufacturers of Urokinase, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Urokinase Sales by Company (2020-2025) & (BIU)

Table 39. North America Urokinase Sales Market Share by Company (2020-2025)

Table 40. North America Urokinase Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Urokinase Revenue Market Share by Company (2020-2025)

Table 42. North America Urokinase Sales by Type (2020-2025) & (BIU)

Table 43. North America Urokinase Sales Market Share by Type (2020-2025)

Table 44. North America Urokinase Sales by Application (2020-2025) & (BIU)

Table 45. North America Urokinase Sales Market Share by Application (2020-2025)

Table 46. Europe Urokinase Sales by Company (2020-2025) & (BIU)

Table 47. Europe Urokinase Sales Market Share by Company (2020-2025)

Table 48. Europe Urokinase Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Urokinase Revenue Market Share by Company (2020-2025)

Table 50. Europe Urokinase Sales by Type (2020-2025) & (BIU)

Table 51. Europe Urokinase Sales Market Share by Type (2020-2025)

Table 52. Europe Urokinase Sales by Application (2020-2025) & (BIU)

Table 53. Europe Urokinase Sales Market Share by Application (2020-2025)

Table 54. China Urokinase Sales by Company (2020-2025) & (BIU)

Table 55. China Urokinase Sales Market Share by Company (2020-2025)

Table 56. China Urokinase Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Urokinase Revenue Market Share by Company (2020-2025)

Table 58. China Urokinase Sales by Type (2020-2025) & (BIU)

Table 59. China Urokinase Sales Market Share by Type (2020-2025)

Table 60. China Urokinase Sales by Application (2020-2025) & (BIU)

Table 61. China Urokinase Sales Market Share by Application (2020-2025)

Table 62. Syner-Med Company Information

Table 63. Syner-Med Description and Business Overview

Table 64. Syner-Med Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)

Table 65. Syner-Med Urokinase Product

Table 66. Syner-Med Recent Development

Table 67. Wanhua Biochem Company Information

Table 68. Wanhua Biochem Description and Business Overview

Table 69. Wanhua Biochem Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)

Table 70. Wanhua Biochem Urokinase Product

Table 71. Wanhua Biochem Recent Development

Table 72. Jiangxi Haoran Bio-Pharma Company Information

Table 73. Jiangxi Haoran Bio-Pharma Description and Business Overview

Table 74. Jiangxi Haoran Bio-Pharma Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)

Table 75. Jiangxi Haoran Bio-Pharma Urokinase Product

Table 76. Jiangxi Haoran Bio-Pharma Recent Development

Table 77. Jiangsu Aidea Pharmaceutical Company Information

Table 78. Jiangsu Aidea Pharmaceutical Description and Business Overview

Table 79. Jiangsu Aidea Pharmaceutical Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)

Table 80. Jiangsu Aidea Pharmaceutical Urokinase Product

Table 81. Jiangsu Aidea Pharmaceutical Recent Development

Table 82. Techpool Company Information

Table 83. Techpool Description and Business Overview

Table 84. Techpool Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)

Table 85. Techpool Urokinase Product

Table 86. Techpool Recent Development

Table 87. Microbic Biosystems Company Information

Table 88. Microbic Biosystems Description and Business Overview

Table 89. Microbic Biosystems Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)

Table 90. Microbic Biosystems Urokinase Product

Table 91. Microbic Biosystems Recent Development

Table 92. LIVZON Company Information

Table 93. LIVZON Description and Business Overview

Table 94. LIVZON Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)

Table 95. LIVZON Urokinase Product

Table 96. LIVZON Recent Development

Table 97. Production Base and Market Concentration Rate of Raw Material

Table 98. Key Suppliers of Raw Materials

Table 99. Urokinase Distributors List

Table 100. Urokinase Customers List

Table 101. Urokinase Market Trends

Table 102. Urokinase Market Drivers

Table 103. Urokinase Market Challenges

Table 104. Urokinase Market Restraints

Table 105. Research Programs/Design for This Report

Table 106. Key Data Information from Secondary Sources

Table 107. Key Data Information from Primary Sources

List of Figures

Figure 1. Urokinase Product Picture

Figure 2. Global Urokinase Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Urokinase Sales Market Share by Type in 2024 & 2031

Figure 4. Urokinase Powder Product Picture

Figure 5. Urokinase Solution Product Picture

Figure 6. Global Urokinase Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 7. Global Urokinase Sales Market Share by Application in 2024 & 2031

Figure 8. Hospital Examples

Figure 9. Clinic Examples

Figure 10. Others Examples

Figure 11. Global Urokinase Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Urokinase Sales Growth Rate (2020-2031) & (US$ Million)

Figure 13. Global Urokinase Sales (BIU) Growth Rate (2020-2031)

Figure 14. Global Urokinase Price Trends Growth Rate (2020-2031) & (US$/MIU)

Figure 15. Urokinase Report Years Considered

Figure 16. Global Market Urokinase Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 17. Global Urokinase Revenue Market Share by Region: 2020 VS 2024

Figure 18. North America Urokinase Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. North America Urokinase Sales (BIU) Growth Rate (2020-2031)

Figure 20. Europe Urokinase Revenue (US$ Million) Growth Rate (2020-2031)

Figure 21. Europe Urokinase Sales (BIU) Growth Rate (2020-2031)

Figure 22. China Urokinase Revenue (US$ Million) Growth Rate (2020-2031)

Figure 23. China Urokinase Sales (BIU) Growth Rate (2020-2031)

Figure 24. Global Urokinase Revenue Share by Type (2020-2025)

Figure 25. Global Urokinase Sales Share by Type (2026-2031)

Figure 26. Global Urokinase Revenue Share by Type (2026-2031)

Figure 27. Global Urokinase Revenue Share by Application (2020-2025)

Figure 28. Global Urokinase Revenue Growth Rate by Application in 2020 & 2024

Figure 29. Global Urokinase Sales Share by Application (2026-2031)

Figure 30. Global Urokinase Revenue Share by Application (2026-2031)

Figure 31. Global Urokinase Sales Share by Company (2024)

Figure 32. Global Urokinase Revenue Share by Company (2024)

Figure 33. Global 5 Largest Urokinase Players Market Share by Revenue in Urokinase: 2020 & 2024

Figure 34. Urokinase Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 35. Manufacturing Cost Structure of Urokinase

Figure 36. Manufacturing Process Analysis of Urokinase

Figure 37. Urokinase Industrial Chain

Figure 38. Channels of Distribution (Direct Vs Distribution)

Figure 39. Distributors Profiles

Figure 40. Bottom-up and Top-down Approaches for This Report

Figure 41. Data Triangulation

Figure 42. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Urokinase in 2025? zhanKai

The global market size of Urokinase in 2025 was 52.1 Million USD.

Which companies rank high in the global Urokinase market? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Urokinase in 2031? shouQi

What is the annual compound growth rate of the global Urokinase market size from 2025 to 2031? shouQi

Related Reports

Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Urokinase market size was US$ 82.09 million in 2025 and is forecast to reach a readjusted size of US$ 120 million by 2032 with a CAGR of 5.2% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 77
USD 4250.00
(Single User License)
Global Urokinase Market Research Report 2026
The global Urokinase market was valued at US$ 82.09 million in 2025 and is anticipated to reach US$ 120 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 116
USD 2900.00
(Single User License)
Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Urokinase was estimated to be worth US$ 82.09 million in 2025 and is projected to reach US$ 120 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 110
USD 3950.00
(Single User License)
Global Urokinase Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Urokinase market is projected to grow from US$ 49.8 million in 2024 to US$ 70.6 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 147
USD 4900.00
(Single User License)
Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Urokinase was estimated to be worth US$ 49.8 million and is forecast to reach approximately US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 121
USD 5900.00
(Single User License)
Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Urokinase was estimated to be worth US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 95
USD 3950.00
(Single User License)
Global Urokinase Market Research Report 2025
The global market for Urokinase was valued at US$ 49.8 million in the year 2024 and is projected to reach a revised size of US$ 70.6 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published Date: 2025-01-16
Pages: 79
USD 2900.00
(Single User License)
Global Urokinase Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published Date: 2024-04-17
Pages: 142
USD 5600.00
(Single User License)
Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published Date: 2024-04-16
Pages: 137
USD 5900.00
(Single User License)
Global Urokinase Market Insights, Forecast to 2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published Date: 2024-04-07
Pages: 89
USD 4900.00
(Single User License)

Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Urokinase market size was US$ 82.09 million in 2025 and is forecast to reach a readjusted size of US$ 120 million by 2032 with a CAGR of 5.2% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 77
USD 4250.00 (Single User License)
Global Urokinase Market Research Report 2026
The global Urokinase market was valued at US$ 82.09 million in 2025 and is anticipated to reach US$ 120 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-01-04
Pages: 116
USD 2900.00 (Single User License)
Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Urokinase was estimated to be worth US$ 82.09 million in 2025 and is projected to reach US$ 120 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-01-04
Pages: 110
USD 3950.00 (Single User License)
Global Urokinase Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Urokinase market is projected to grow from US$ 49.8 million in 2024 to US$ 70.6 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 147
USD 4900.00 (Single User License)
Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Urokinase was estimated to be worth US$ 49.8 million and is forecast to reach approximately US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 121
USD 5900.00 (Single User License)
Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Urokinase was estimated to be worth US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 95
USD 3950.00 (Single User License)
Global Urokinase Market Research Report 2025
The global market for Urokinase was valued at US$ 49.8 million in the year 2024 and is projected to reach a revised size of US$ 70.6 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published: 2025-01-16
Pages: 79
USD 2900.00 (Single User License)
Global Urokinase Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published: 2024-04-17
Pages: 142
USD 5600.00 (Single User License)
Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published: 2024-04-16
Pages: 137
USD 5900.00 (Single User License)
Global Urokinase Market Insights, Forecast to 2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published: 2024-04-07
Pages: 89
USD 4900.00 (Single User License)